Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2008

01-02-2008 | Glaucoma

Mitomycin C induces multidrug resistance in glaucoma surgery

Authors: Arno Hueber, Johannes M. Esser, Norbert Kociok, Gerhard Welsandt, Christoph Lüke, Sigrid Roters, Peter J. Esser

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 2/2008

Login to get access

Abstract

Background

Despite the adjuvant use of mitomycin C during trabeculectomy, failures still occur. We investigated whether cultured human Tenon fibroblasts exposed to low-dose mitomycin C developed a multidrug resistance phenotype in vitro, and whether mitomycin C treatment during previous filtration surgery induces P-glycoprotein expression in vivo.

Methods

Cultured human Tenon fibroblasts treated with low-dose 0.01 nM mitomycin C for 2 weeks were subsequently treated with 0.1 to 100 μM mitomycin C in the absence or presence of 4 μM verapamil, and allowed to recover for 24 hours. Low-dose mitomycin C-treated fibroblasts were analysed for P-glycoprotein expression using flow cytometry, immunoblotting, and RT-PCR for mdr-1 mRNA. In addition, fibroblasts were treated with low dose 0.1 nM 5-fluorouracil for 2 weeks and analysed for P-glycoprotein expression using flow cytometry. Expression of P-glycoprotein was analysed in surgically removed Tenon tissue (n = 30) using immunohistochemistry. Of the 30 patients, 20 had a previous trabeculectomy, of which nine had previous adjuvant therapy with mitomycin C during trabeculectomy.

Results

Partial resistance to mitomycin C after low-dose mitomycin C pre-treatment was significantly neutralised by the addition of verapamil. Low-dose mitomycin C up-regulated P-glycoprotein expression, but not mdr-1 mRNA expression. 5-Fluorouracil did not induce P-glycoprotein expression. P-glycoprotein expression was detected in all nine patients exposed to mitomycin C during previous trabeculectomies. Only six of 21 specimens from patients not previously exposed to mitomycin C showed faint P-glycoprotein expression.

Conclusion

The induction of P-glycoprotein by mitomycin C could explain some failures that occur after repeated use of mitomycin C during trabeculectomy. The concomitant use of verapamil or the use of 5-fluorouracil alone could increase the success rate of repeat trabeculectomies.
Literature
1.
go back to reference Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R (1998) Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol 126:648–657PubMedCrossRef Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R (1998) Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol 126:648–657PubMedCrossRef
2.
go back to reference Bellamy WT (1996) P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36:161–183PubMedCrossRef Bellamy WT (1996) P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36:161–183PubMedCrossRef
3.
go back to reference Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673–679PubMed Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673–679PubMed
4.
go back to reference Chang MR, Cheng Q, Lee DA (1998) Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther 14:75–95PubMedCrossRef Chang MR, Cheng Q, Lee DA (1998) Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther 14:75–95PubMedCrossRef
5.
go back to reference Chen LX, Wang LW, Jacob T (2002) The role of MDR1 gene in volume-activated chloride currents in pigmented ciliary epithelial cells. Sheng Li Xue Bao 54:1–6PubMed Chen LX, Wang LW, Jacob T (2002) The role of MDR1 gene in volume-activated chloride currents in pigmented ciliary epithelial cells. Sheng Li Xue Bao 54:1–6PubMed
6.
go back to reference Chin KV, Pastan I, Gottesman MM (1993) Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157–180PubMed Chin KV, Pastan I, Gottesman MM (1993) Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157–180PubMed
7.
go back to reference Dunia I, Smit JJ, van der Valk MA, Bloemendal H, Borst P, Benedetti EL (1996) Human multidrug resistance 3-P-glycoprotein expression in transgenic mice induces lens membrane alterations leading to cataract. J Cell Biol 132:701–716PubMedCrossRef Dunia I, Smit JJ, van der Valk MA, Bloemendal H, Borst P, Benedetti EL (1996) Human multidrug resistance 3-P-glycoprotein expression in transgenic mice induces lens membrane alterations leading to cataract. J Cell Biol 132:701–716PubMedCrossRef
8.
go back to reference Esser J, Esser P, Mietz H, Hueber A, Kociok N, Schraermeyer U, Krieglstein GK (2000) Multidrug resistance-associated proteins in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 238:727–732PubMedCrossRef Esser J, Esser P, Mietz H, Hueber A, Kociok N, Schraermeyer U, Krieglstein GK (2000) Multidrug resistance-associated proteins in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 238:727–732PubMedCrossRef
9.
go back to reference Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M (1998) Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:164–170PubMed Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M (1998) Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:164–170PubMed
10.
go back to reference Hodgkinson R, Sharples D (2002) Reversing antibiotic resistance. Expert Opin Investig Drugs 11:1023–1032PubMedCrossRef Hodgkinson R, Sharples D (2002) Reversing antibiotic resistance. Expert Opin Investig Drugs 11:1023–1032PubMedCrossRef
11.
go back to reference Johnstone RW, Ruefli AA, Tainton KM, Smyth MJ (2000) A role for P-glycoprotein in regulating cell death. Leuk Lymphoma 38:1–11PubMed Johnstone RW, Ruefli AA, Tainton KM, Smyth MJ (2000) A role for P-glycoprotein in regulating cell death. Leuk Lymphoma 38:1–11PubMed
12.
go back to reference Kawazu K, Yamada K, Nakamura M, Ota A (1999) Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest Ophthalmol Vis Sci 40:1738–1744PubMed Kawazu K, Yamada K, Nakamura M, Ota A (1999) Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest Ophthalmol Vis Sci 40:1738–1744PubMed
13.
go back to reference Kim RB (2002) Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 34:47–54PubMedCrossRef Kim RB (2002) Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 34:47–54PubMedCrossRef
14.
go back to reference Kippenberger S, Loitsch S, Solano F, Bernd A, Kaufmann R (1998) Quantification of tyrosinase, TRP-1, and Trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR–regulation by steroid hormones. J Invest Dermatol 110:364–367PubMedCrossRef Kippenberger S, Loitsch S, Solano F, Bernd A, Kaufmann R (1998) Quantification of tyrosinase, TRP-1, and Trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR–regulation by steroid hormones. J Invest Dermatol 110:364–367PubMedCrossRef
15.
go back to reference Knagenhjelm SK, Frøyland K, Ringvold A, Bjerkås E, Kjønniksen I (1999) Toxicological evaluation of cyclosporine eyedrops. Acta Ophthalmol Scand 77:200–203PubMedCrossRef Knagenhjelm SK, Frøyland K, Ringvold A, Bjerkås E, Kjønniksen I (1999) Toxicological evaluation of cyclosporine eyedrops. Acta Ophthalmol Scand 77:200–203PubMedCrossRef
17.
go back to reference Lum BL, Gosland MP (1995) MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol Oncol Clin North Am 9:319–336PubMed Lum BL, Gosland MP (1995) MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol Oncol Clin North Am 9:319–336PubMed
18.
go back to reference Melena J, Zalduegui A, Arcocha P, Santafé J, Segarra J (1999) Topical verapamil lowers outflow facility in the rabbit eye. J Ocul Pharmacol Ther 15:199–205PubMed Melena J, Zalduegui A, Arcocha P, Santafé J, Segarra J (1999) Topical verapamil lowers outflow facility in the rabbit eye. J Ocul Pharmacol Ther 15:199–205PubMed
19.
go back to reference Merriman-Smith BR, Young MA, Jacobs MD, Kistler J, Donaldson PJ (2002) Molecular identification of P-glycoprotein: a role in lens circulation? Invest Ophthalmol Vis Sci 43:3008–3015PubMed Merriman-Smith BR, Young MA, Jacobs MD, Kistler J, Donaldson PJ (2002) Molecular identification of P-glycoprotein: a role in lens circulation? Invest Ophthalmol Vis Sci 43:3008–3015PubMed
20.
go back to reference Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK (1996) Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 234:364–368PubMedCrossRef Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK (1996) Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 234:364–368PubMedCrossRef
21.
go back to reference Mietz H, Krieglstein GK (1998) Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers 29:628–634PubMed Mietz H, Krieglstein GK (1998) Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers 29:628–634PubMed
22.
go back to reference Shin DH, Kardasis CT, Kim C, Bsee, Juzych MS, Mhsa, Hughes BA, Keole NS (2001) Topical verapamil in glaucoma filtration surgery. J Glaucoma 10:211–214PubMedCrossRef Shin DH, Kardasis CT, Kim C, Bsee, Juzych MS, Mhsa, Hughes BA, Keole NS (2001) Topical verapamil in glaucoma filtration surgery. J Glaucoma 10:211–214PubMedCrossRef
23.
go back to reference Takara K, Sakaeda T, Okumura K (2006) An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. Curr Pharm Des 12:273–286PubMedCrossRef Takara K, Sakaeda T, Okumura K (2006) An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. Curr Pharm Des 12:273–286PubMedCrossRef
24.
go back to reference Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954–964PubMedCrossRef Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954–964PubMedCrossRef
25.
go back to reference Yang JJ, Kim KJ, Lee VH (2000) Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm Res 17:533–538PubMedCrossRef Yang JJ, Kim KJ, Lee VH (2000) Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm Res 17:533–538PubMedCrossRef
26.
go back to reference Zhang JJ, Jacob TJ (1994) ATP-activated chloride channel inhibited by an antibody to P glycoprotein. Am J Physiol 267:C1095–1102PubMed Zhang JJ, Jacob TJ (1994) ATP-activated chloride channel inhibited by an antibody to P glycoprotein. Am J Physiol 267:C1095–1102PubMed
Metadata
Title
Mitomycin C induces multidrug resistance in glaucoma surgery
Authors
Arno Hueber
Johannes M. Esser
Norbert Kociok
Gerhard Welsandt
Christoph Lüke
Sigrid Roters
Peter J. Esser
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2008
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-007-0695-1

Other articles of this Issue 2/2008

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2008 Go to the issue